184. El-Roiey A, Gross WL, Ludeman J, Isenberg DA, Shoenfeld Y. Preferential secretion of common anti-DNA idiotype (16/6 Id) and anti-polynucleotide antibodies by mononuclear cells, following stimulation with Klebsiella pneumonia. Immunol Lett 12:313-319, 1986.
198. Sela O, El-Roeiy A, Isenberg DA, Kennedy RC, Colaco CB, Pinkhas J, Shoenfeld Y. A common anti-DNA antibody idiotype in sera of patients with active pulmonary tuberculosis. Arthritis Rheum 30:50-55, 1987.
204. El-Roeiy A, Sela O, Isenberg DA, Kennedy RL, Shoenfeld Y. The sera of patients with
Klebsiella infections contain a common anti-DNA idiotype (16/6 Id) and antipolynucleotide activity. Clin Exp Immunol 67:507-515, 1987.
207. Isenberg DA, Maddison P, Swana G, Jones M, Dudeney C, El-Roeiy A, Shoenfeld Y.
Profile of autoantibodies in the sera of patients with tuberculosis, Klebsiella and other gram-negative infections. Clin Exp Immunol 67: 516-523, 1987.
211. Teplizki H, Buskila D, Isenberg DA, Coates ARM, Sukenik S, Horowitz J, Shoenfeld Y.
Low serum anti-TB glycolipid antibodies titer in the sera of patients with SLE as an indicator of CNS involvement. J Rheumatol 14:507, 1987.
214. Isenberg DA, Feldman R, Dudeney C, Konikoff F, Jones D, Erbinger A, Shoenfeld Y. A study of anti-polynucleotide antibodies, anti-Klebsiella (K30) antibodies and anti-DNA antibody idiotypes in ankylosing spondylitis. Brit J Rheumatol 26:168-171, 1987.
241. Shoenfeld Y, Isenberg DA. Mycobacteria and autoimmunity. Immunology Today 9:178-
181, 1988.
278. Argov S, Jaffe C, Krupp M, Slor H, Shoenfeld Y. Autoantibody production by patients with Leishmania. Clin Exp Immunol 76:190-197, 1989.
305. Thomas MAB, Frampton G, Isenberg DA, Shoenfeld Y, Akinsola A, Ramzy M,
Lilliywhite J, Williams DGA. Common anti-DNA idiotype and anti-phospholipid antibodies in sera from patients with schistosomiasis and filariasis with and without nephritis. J Autoimmunity 2:803-812, 1989.
350. Abu-Shakra M, Shoenfeld Y. Parasitic infection and autoimmunity. Autoimmunity
9:337-344, 1991.
458.
Rahima D, Tarrab-Hazdai R, Blank M, Arnon R, Shoenfeld Y. Anti-nuclear antibodies associated with schistosomiasis and anti-schistosomal antibodies associated with SLE.
Autoimmunity 17:127-141, 1994.
485. Hojnik M, Gilburd B, Ziporen L, Blank M, Tomer Y, Scheinberg MA, Tincani A, Rozman B,
Shoenfeld Y. Anticardiolipin antibodies in infections are heterogeneous in their dependency on

2
-glycoprotein I: Analysis of anticardiolipin antibodies in leprosy. Lupus 3:515-521, 1994.
523. George J, Shoenfeld Y. Infections, idiotypes and SLE. Lupus 4:333-335, 1995.
529. Finkelstein Y, Adler Y, Levy Y, Youinou P, Shoenfeld Y. Viral myocarditis: are we dealing with an autoimmune phenomenon? Ann Med Intern 146:322-324, 1995.

531. Terryberry J, Sutjita M, Shoenfeld Y, Gilburd B, Tanne D, Lorber M, Alosachie L, Barka
N, Lin HC, Youinou P, Peter JB. Myelin-and microbe-specific antibodies in Guillain-
Barre syndrome. J Clin Lab Analysis 9:308-319, 1995.
536. Cohen A, Shoenfeld Y. The viral autoimmunity relationship. Viral Immunology 8:1-9,
1995.
551. Guedes L.S, Barbosa B, Gilburd B, Shoenfeld Y,Scheinberg M.A. Autoantibodies in leprosy sera , Clin Rheumatol 15:26-28, 1996.
561. George J, Shoenfeld Y. Fungal infections and autoimmune diseases. Harefuah 130: 388 - 390,
1996.
578. Shoenfeld Y. Common infections, idiotypic dysregulation, autoantibody spread and induction of autoimmune diseases. J Autoimmunity 9: 235 - 239, 1996.
586. George J, Levy Y, Shoenfeld Y. Infections and autoimmunity - emerging clinical trials.
Turk J Immunol 1: 11-13, 1996.
593. Baharav E, Gur H, Fishman P, Ziporen L, Blank M, Aelion J, Kotb M, Shoenfeld Y.
Superantigens and experimental SLE induced by idiotypic dysregulation. Clin Exp
Rheumatol 14: 359 - 366, 1996.
599. Galperin C, Shoenfeld Y, Gilburd B, Esterre P, Meroni PL, Del Papa N, Halpern GM,
Andriantsimahavandy A, Gershwin ME. Anti-neutrophil cytoplasmic antibodies in patients with chromomycosis. Clin Exp Rheumatol 14: 479-483, 1996.
612.
Tishler M, Shoenfeld Y. Anti-heat-shock protein antibodies in rheumatic and autoimmune diseases. Semin Arthritis Rheum 26: 558-563, 1996.
616.
Tishler M, Shoenfeld Y. Tuberculose et auto-immunite: ou en sommes - nous ? Annales de L Institut Pasteur 7: 133-136, 1996.
625.
Cohen AD, Shoenfeld Y. Vaccine-induced Autoimmunity. J Autoimmunity 9: 699-703,
1996.
652.
George J, Levy Y, Kallenberg CGM, Shoenfeld Y. Infections and Wegener s granulomatosis - a cause and effect relationship? Q J Med 90: 367-373,1997.
679.
Buskila D, Sikuler E, Shoenfeld Y. Hepatitis C virus, autoimmunity and rheumatic disease. Lupus 6: 685-690, 1997.
683. Sherer Y, Shoenfeld Y. Infectious agents and atherosclerosis. Harefuah 134: 204-207,
1998.
684. Barak V, Schwartz A, Kalichman I, Nisman B, Gurman G, Shoenfeld Y. Prevalence of hypophosphatemia in sepsis and infection: The role of cytokines. Amer J Med 104: 40-
47, 1998.
701.
Mason AL, Xu L, Guo L, Munoz S, Jaspan JB, Bryer-Ash M, Sander DM, Shoenfeld Y,
Ahmed A, Van de Water J, Gershwin ME, Garry RF. Detection of retroviral antibodies in primary biliary cirrhosis and other idiopathic biliary disorders. Lancet , 351: 1620-1624:
1998.
705.
Afek A, Kopulovic J, Shoenfeld Y. Cytomegalovirus and atherosclerosis. Harefuah 134:
869-871, 1998.
720.
Terryberry JW., Shoenfeld Y., Peter J. B. Clinical utility of autoantibodies in Guillain-
Barre syndrome and its variants. Clin Rev Allergy & Immunol. 16: 265-273, 1998.
724.
George J, Patnaik M, Bakshi E, Levy Y, Ben-Daviv A, Ahmed A, B. Peter J, Shoenfeld Y.
Hantavirus seropositivity in Israeli patients with renal failure. Viral Immunol. 11: 103-8, 1998.
794.
Abu Shakra M, Buskila D, Shoenfeld Y. Molecular mimicry between host and pathogen: examples from parasites and implication. Immunology Letters 67: 147-152, 1999

835
.
Asherson Ronald A, Shoenfeld Y. The role of infection in the pathogenesis of catastrophic antiphospholipid syndrome - molecular mimicry? J Rheumatol, 27: 1: 12-14, 2000.
872.
Bar-Meir E, Amital H, Levy Y, Kneller A, Bar-Daya Y, Shoenfeld Y. Mycoplasmapneumoniae- induced thrombotic thrombocytopenic purpura. Acta Haematologica. 103: 112-
115, 2000.
891. Shoenfeld Y, Blank M, Krause I. The relationship of anti-phospholipid antibodies to infections - do they bind to infecting agents or may they even be induced by them? Clin Exp Rheum 18: 431-
2, 2000.
945. Leder AN, Flansbaum B, Zandman-Goddard G, Asherson R, Shoenfeld Y. Antiphospholipid syndrome induced by HIV. Lupus 10: 370-374, 2001.
947.
Von-Landenberg P, Shoenfeld Y. New approaches in the diagnosis of sepsis. IMAJ 3: 439-442,
2001.
951. Zandman-Goddard G, Shoenfeld Y. HIV and Autoimmunity. http/www.rheuma21st.com/archives file:////Shoenfeld/public/REPRINT…report_zandmann_shoenfeld_hiv.html , 2001, 1-11.
993. Blank M, Krause aI, Fridkin M, Keller N, Kopolovic J, Goldberg I, Tobar A, Shoenfeld Y.
Bacterial I induction of autoantibodies to β2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome. J Clin Invest 109: 797-804, 2002.
1002. Shoenfeld Y. Infection and atherosclerosis - impact on autoimmune rheumatic disease,
Washington D.C., USA 29-30 April 2002 - Report. http/www/rheuma21st.com/archives/report_infection_atherosclerosis.html , 2002.
1023. Schwarz A, Furman G, Cohen G, Gilutz H, Brill S, Schily M, Gurevitch B, Shoenfeld Y.
Association between hypophosphatemia and cardiac arrhythmias in the early stages of sepsis.
Eur. J Int Med 13: 434-438, 2002.
1031. Zandman-Goddard G, Shoenfeld Y. HIV and autoimmunity. Autoimmun Rev 1/6: 329-337, 2002.
1039.
Shoenfeld Y. Etiology and pathogenetic mechanisms of the anti-phospholipid syndrome unreaveled.
Trends in Immunology 24: 2-4, 2003.
1044. Asherson RA, Shoenfeld Y. Human immunodeficiency virus infection, antiphospholipid antibodies, and the antiphospholipid syndrome. J Rheum 30: 214-219, 2003.
1067. Rotman - Pikielny P, Levy Y, Eyal A, Shoenfeld Y. Pyomyositis or "injectiositis" – staphylococcus aureus multiple abscesses following intramuscular injections. IMAJ 5: 295-296, 2003.
1072. Zandman-Goddard G, Shoenfeld Y. SLE and infections. Clin Rev Allergy & Immunol 25: 29-
40, 2003.
1112. Blank M, Asherson R.A., Cervera R, Shoenfeld Y. Antiphospholipid syndrome infectious origin. J Clin Immunol 24: 12-23, 2004.
1116. Pierangeli S.S., Blank M, Liu X, Espinola R, Fridkin M, Ostertag MV, Roye-Green K, Harris
EN, Shoenfeld Y. A peptide that shares similarity with bacterial antigens reverses thrombogenic properties of antiphospholipid antibodies in vivo. J Autoimmun 22: 217-225, 2004.
1124. Shlyakhov E, Shoenfeld Y, Gilburd B, Rubinstein E. Evaluation of Bacillus anthracis extractable antigen for testing anthrax immunity. Clin Microbiol Infect 10: 421-424, 2004.
1139. Shoenfeld Y, Blank M. The infectious etiology of the antiphospholipid syndrome (APS). Aut Rev
3 Suppl. 1: 532-34, 2004.
1160. Strous RD, Shoenfeld Y. Revisiting old ghosts: prenatatl viral exposure and schizophrenia. IMAJ
7: 43-45, 2005.
1162. Khamaisi M, Shoenfeld Y, Orbach H. Guillain-Barre syndrome following hepatitis B vaccination.
Clin & Exp Rheumatol 22: 767-770, 2004.
1231. Harel M, Aron-Maor A, Sherer Y, Bloank M, Shoenfeld Y. The infectious etiology of the antiphospholipid syndrome: links between infection and autoimmunity. Immunobiol 210: 743-
747, 2005.

1239. Shoenfeld Y, Blank M, Cervera R, Font J, Raschi E, Meroni PL. Infectious origin of the antiphospholipid syndrome. Ann Rheum Dis 65: 2-6, 2006.